Short description
Exiqon operates in two business areas, Life Sciences and Diagnostics.
Description
Exiqon operates in two business areas: Life Sciences and Diagnostics.
Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and the development of cancer and other diseases.
Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.
Last funding
Cannot Access
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Vedbæk, Hovedstaden, Denmark, Europe
Founded on
January 1, 1995
Exited on
June 8, 2007
Went public on
June 8, 2007
Delisted on
July 11, 2016
Stock symbol
EXQ
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh, Noway Youcantaccess, Noaccess, Noaccess, Noaccess, Uh Ohhhh
Sign in for full access
Founders
Troels Koch